Magnesium and prochlorperazine for the treatment of migraines: An interim analysis of MAGraine-2

Authors

• Thomas Szwajnos, Advocate Health - MidwestFollow
• Samar Ashrafi, Advocate Health - MidwestFollow
• Ryan McKillip, Advocate Health - MidwestFollow
• Kara Fifer, Advocate Health - MidwestFollow
• Cathrine Roels, Advocate Health - MidwestFollow
• Nadine Lomotan, Advocate Health MidwestFollow
• Barb Bukowski Gorno, Advocate Health - MidwestFollow
• Alyse Rehberger, Advocate Health - MidwestFollow
• Cindy Ndiaye, Advocate Health - MidwestFollow
• David Huynh, Advocate Health - MidwestFollow
• Michael Cirone, Advocate Health - MidwestFollow
• Ravi Chacko, Advocate Health - MidwestFollow
• Travis Hase, Advocate Health - MidwestFollow
• Loredana C. Huma, Advocate Health - MidwestFollow
• Marc McDowell, Advocate Health - MidwestFollow

Recommended Citation

Szwajnos T, Ashrafi S, McKillip R, Fifer K, Roels C, Lomotan N, Bukowski Gorno B, Rehberger A, Ndiaye C, Huynh D, Cirone M, Chacko R, Hase T, Huma L, McDowell M. Magnesium and Prochlorperazine for the Treatment of Migraines: An Interim Analysis of MAGraine-2. Presentation at: American College of Emergency Physicians Scientific Assembly 2026; October 5, 2026; Chicago, IL.

Affiliations

Advocate Good Shepherd Hospital, Advocate Christ Medical Center

Presentation Notes

Presentation at: American College of Emergency Physicians Scientific Assembly 2026; October 5, 2026; Chicago, IL.

Type

Oral/Podium Presentation